-
Early Data Show 3-Year Survival Benefit, Potential Temferon-Mediated Disease Control in Glioblastoma Multiforme
01 Jul 2025 21:03 GMT
… 2 patients with newly diagnosed glioblastoma multiforme from the phase 1… with glioma and glioblastoma multiforme in the European Union, and glioblastoma multiforme in the … to Temferon for treatment of glioblastoma multiforme. News release. Genenta Science. …
-
Pelotonia returns to Licking County on Aug. 2-3. What you need to know
02 Aug 2025 01:13 GMT
… died 11 years later from glioblastoma multiforme, a fast-growing and aggressive …
-
Severe Unilateral Alopecia in a Long-Term Surviving Male Adolescent Glioblastoma Multiforme Patient
06 Jun 2025 12:20 GMT
… solid malignancies.1 Furthermore, pediatric glioblastoma multiforme (p-GBM) cases demonstrate particularly … pathways and therapeutic approaches in glioblastoma multiforme (Review). Int J Oncol. 2022 …
-
HADHA Controls JAK/STAT3 in Glioblastoma via Metabolism
01 Aug 2025 18:56 GMT
… could revolutionize current treatment paradigms.
Glioblastoma multiforme (GBM) represents a dire medical …
-
Marsal Therapeutics discovers new compounds to treat glioblastoma multiforme
08 Apr 2025 18:00 GMT
-
Top Growth Driver In The Glioblastoma Multiforme Market 2025: Rising Cases Of Brain Disorders Fuels Growth In Market
25 Mar 2025 13:29 GMT
… of The Glioblastoma Multiforme Market In The Foreseeable Future?
The glioblastoma multiforme market size … In The Glioblastoma Multiforme Market?
Prominent companies operating in the glioblastoma multiforme market include …
-
Potential Causal Relationship Between Plasma and Cerebrospinal Fluid Metabolites and Meningioma: Two-Sample Mendelian Randomization Study
30 Jul 2025 16:47 GMT
… -translational modification: shedding light on Glioblastoma multiforme. BBA-Rev Cancer. 2023;1878 …
-
Glioblastoma Multiforme
11 Mar 2025 12:22 GMT
Medidata AI’s Synthetic Control Arm® (SCA®) leverages historical clinical trial data (HCTD) to provide a more relevant clinical insight for the purpose of developing new therapies. In comparison to RWD, HCTD based SCAs utilize “regulatory grade” data, …
-
Timothy Seif (1971 – 2025)
29 Jul 2025 22:14 GMT
… courageous 14-year battle with glioblastoma multiforme grade 4 brain cancer.
He …
-
Glioblastoma Multiforme Treatment Market to Hit US$ 4.7 Billion by 2033
06 Feb 2025 06:08 GMT
… the classification of the Glioblastoma Multiforme Treatment market, highlighting significant … , and trends shaping the Glioblastoma Multiforme Treatment industry.
• It … businesses navigate the Global Glioblastoma Multiforme Treatment market effectively.
• …